Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Residual Antimicrobial Activity of IonLAST
NCT04495920Phase 1Completed
- Sponsor
- CAGE Bio
- Start
- Jun 2020
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of choline geranate in bacterial skin colonization, sponsored by CAGE Bio. Primary endpoint: Significant Log 10 Microbial Change 4 hours post application. Started Jun 2020; status: completed.
02
Drugs
choline geranate
03
Conditions
bacterial skin colonization
Beyond the preview
Go deeper on NCT04495920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04495920.